| 0.0848 -0.012 (-12.67%) | 10-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.12  |
1-year : | 1.76 |
| Resists | First : | 0.96 |
Second : | 1.5 |
| Pivot price | 0.36 |
|||
| Supports | First : | 0.08 |
Second : | 0.06 |
| MAs | MA(5) : | 0.11 |
MA(20) : | 0.49 |
| MA(100) : | 3.03 |
MA(250) : | 91.75 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 1.1 |
D(3) : | 1.3 |
| RSI | RSI(14): 17.2 |
|||
| 52-week | High : | 477 | Low : | 0.08 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ XXII ] has closed above bottom band by 22.2%. Bollinger Bands are 56.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 176 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.09 - 0.09 | 0.09 - 0.09 |
| Low: | 0.08 - 0.08 | 0.08 - 0.08 |
| Close: | 0.08 - 0.08 | 0.08 - 0.09 |
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Thu, 29 Oct 2026
22nd Century Group partners with Gopuff to sell... - Pluang
Thu, 29 Oct 2026
22nd Century Signs Groundbreaking Agreement with Gopuff - The Manila Times
Thu, 29 Oct 2026
symbol__ Stock Quote Price and Forecast - CNN
Thu, 29 Oct 2026
22nd Century Group, Inc. (XXII) stock price, news, quote and history - Yahoo Finance Singapore
Wed, 28 Oct 2026
22nd Century Group, Inc. (XXII) stock price, news, quote and history - Yahoo Finance UK
Wed, 28 Oct 2026
22nd Century Group Adds Clear Street as Sales Agent to Existing Sales Agreement - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Tobacco
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 5.4 (%) |
| Held by Institutions | 1.9 (%) |
| Shares Short | 38 (K) |
| Shares Short P.Month | 43 (K) |
| EPS | 78.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 37.06 |
| Profit Margin | -76.1 % |
| Operating Margin | -247.9 % |
| Return on Assets (ttm) | -31 % |
| Return on Equity (ttm) | -105.8 % |
| Qtrly Rev. Growth | -40.5 % |
| Gross Profit (p.s.) | -3.95 |
| Sales Per Share | 7.24 |
| EBITDA (p.s.) | -15.62 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.01 |
| Price to Cash Flow | -0.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|